Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 5;27(2):87.
doi: 10.3892/ol.2024.14221. eCollection 2024 Feb.

Gut microbiota influences the efficiency of immune checkpoint inhibitors by modulating the immune system (Review)

Affiliations
Review

Gut microbiota influences the efficiency of immune checkpoint inhibitors by modulating the immune system (Review)

Haihong Jiang et al. Oncol Lett. .

Abstract

Immune checkpoint inhibitors (ICIs) are commonly utilized in tumor treatment. However, they still have limitations, including insufficient effectiveness and unavoidable adverse events. It has been demonstrated that gut microbiota can influence the effectiveness of ICIs, although the precise mechanism remains unclear. Gut microbiota plays a crucial role in the formation and development of the immune system. Gut microbiota and their associated metabolites play a regulatory role in immune balance. Tumor occurrence and development are linked to their ability to evade recognition and destruction by the immune system. The purpose of ICIs treatment is to reinitiate the immune system's elimination of tumor cells. Thus, the immune system acts as a communication bridge between gut microbiota and ICIs. Varied composition and characteristics of gut microbiota result in diverse outcomes in ICIs treatment. Certain gut microbiota-related metabolites also influence the therapeutic efficacy of ICIs to some extent. The administration of antibiotics before or during ICIs treatment can diminish treatment effectiveness. The utilization of probiotics and fecal transplantation can partially alter the outcome of ICIs treatment. The present review synthesized previous studies to examine the association between gut microbiota and ICIs, elucidated the role of gut microbiota and its associated factors in ICIs treatment, and offered direction for future research.

Keywords: fecal transplantation; gut microbiota; immune checkpoint inhibitors; immune system; immunotherapy; probiotics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1.
Figure 1.
The role of gut microbiota in ICIs. Some members and characteristics of gut microbiota can enhance the efficiency of ICIs, while others can weaken it. According to different reports, some metabolites related to gut microbiota can enhance the efficiency of ICIs, while others can attenuate the efficiency of ICIs. The application of antibiotics in general attenuates the efficiency of ICIs. In general, the application of probiotics can enhance the efficiency of ICIs, but some studies have reported that the application of probiotics can weaken the efficiency of ICIs. Fecal transplantation can enhance the efficiency of ICIs. ICIs, immune checkpoint inhibitors.

Similar articles

Cited by

References

    1. Christofi T, Baritaki S, Falzone L, Libra M, Zaravinos A. Current perspectives in cancer immunotherapy. Cancers (Basel) 2019;11:1472. doi: 10.3390/cancers11101472. - DOI - PMC - PubMed
    1. Gupta SL, Basu S, Soni V, Jaiswal RK. Immunotherapy: An alternative promising therapeutic approach against cancers. Mol Biol Rep. 2022;49:9903–9913. doi: 10.1007/s11033-022-07525-8. - DOI - PMC - PubMed
    1. Kennedy LB, Salama AKS. A review of cancer immunotherapy toxicity. CA Cancer J Clin. 2020;70:86–104. doi: 10.3322/caac.21596. - DOI - PubMed
    1. Shi Z, Li H, Song W, Zhou Z, Li Z, Zhang M. Emerging roles of the gut microbiota in cancer immunotherapy. Front Immunol. 2023;14:1139821. doi: 10.3389/fimmu.2023.1139821. - DOI - PMC - PubMed
    1. Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G, Libra M. Gut microbiota and cancer: From pathogenesis to therapy. Cancers (Basel) 2019;11:38. doi: 10.3390/cancers11010038. - DOI - PMC - PubMed